{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T17:04:17Z","timestamp":1777395857973,"version":"3.51.4"},"reference-count":43,"publisher":"SAGE Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2023,1,17]]},"abstract":"<jats:p>Background: Cerebral small vessel disease (CSVD), which comprises the typical features of white matter hyperintensity (WMH) and Vichor-Robin spaces (VRSs) in the brain, is one of the leading causes of aging-related cognitive decline and, ultimately, contributes to the occurrence of dementia, including Alzheimer\u2019s disease (AD). Objective: To investigate whether CSVD imaging markers modify the pathological processes of AD and whether these markers improve AD diagnosis. Methods: 208 participants were enrolled in the China Aging and Neurodegenerative Initiative (CANDI). Fluid AD biomarkers were detected using a single-molecule array, and cerebral small vessel dysfunction was determined using magnetic resonance imaging. Results: WMH contributed to AD pathology only within the NC and MCI groups (CDR \u22640.5), whereas VRSs had no effect on AD pathology. The associations between AD biomarkers and cognitive mental status were consistent with the presence of CSVD pathology. That is, within individuals without CSVD pathology, the MMSE scores were correlated with AD fluid biomarkers, except for plasma A\u03b242 and A\u03b240. Increased plasma p-Tau levels were associated with worse cognitive performance in individuals with WMH (\u03b2=\u200a\u20130.465, p\u200a=\u200a0.0016) or VRSs (\u03b2=\u200a\u20130.352, p\u200a=\u200a0.0257) pathology. Plasma AD biomarkers combined with CSVD markers showed high accuracy in diagnosing dementia. Conclusion: Findings from this cross-sectional cohort study support the notion that CSVD is a risk factor for dementia and highlights that vascular pathology can promote AD biomarker levels, especially in the early course of the disease. Moreover, our results suggest that adding a vascular category to the ATN framework improves the diagnostic accuracy of AD.<\/jats:p>","DOI":"10.3233\/jad-220872","type":"journal-article","created":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T10:10:18Z","timestamp":1670580618000},"page":"795-804","source":"Crossref","is-referenced-by-count":3,"title":["Features of Cerebral Small Vessel Disease Contributes to the Differential Diagnosis of Alzheimer\u2019s Disease"],"prefix":"10.1177","volume":"91","author":[{"given":"Zhao-Zhao","family":"Cheng","sequence":"first","affiliation":[{"name":"Cheeloo College of Medicine, Shandong University, Jinan, China"},{"name":"Department of Neurology, Institute on Aging and Brain Disorders, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Neurology, Institute on Aging and Brain Disorders, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin-Yi","family":"Lv","sequence":"additional","affiliation":[{"name":"Department of Neurology, Institute on Aging and Brain Disorders, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiong","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Institute on Aging and Brain Disorders, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Neurology, Institute on Aging and Brain Disorders, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bao-Liang","family":"Sun","sequence":"additional","affiliation":[{"name":"The Second Affiliated Hospital, Shandong First Medical University & Shandong Academy of Medical Sciences, Taian, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Shen","sequence":"additional","affiliation":[{"name":"Department of Neurology, Institute on Aging and Brain Disorders, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-220872_ref1","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/nn.2583","article-title":"Amyloid-beta-induced neuronal dysfunction in Alzheimer\u2019s disease: From synapses toward neural networks","volume":"13","author":"Palop","year":"2010","journal-title":"Nat Neurosci"},{"key":"10.3233\/JAD-220872_ref2","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/s41582-020-00435-y","article-title":"Neuroinflammation and microglial activation in Alzheimer disease: Where do we go from here?","volume":"17","author":"Leng","year":"2021","journal-title":"Nat Rev Neurol"},{"key":"10.3233\/JAD-220872_ref3","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA Research Framework: Toward a biological definition of Alzheimer\u2019s disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-220872_ref4","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/nrn.2017.48","article-title":"Cerebral blood flow regulation and neurovascular dysfunction in Alzheimer disease","volume":"18","author":"Kisler","year":"2017","journal-title":"Nat Rev Neurosci"},{"key":"10.3233\/JAD-220872_ref5","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jalz.2018.07.222","article-title":"Vascular dysfunction-The disregarded partner of Alzheimer\u2019s disease","volume":"15","author":"Sweeney","year":"2019","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-220872_ref6","doi-asserted-by":"crossref","first-page":"e1920780","DOI":"10.1001\/jamanetworkopen.2019.20780","article-title":"Association of vascular risk factors with beta-amyloid peptide and tau burdens in cognitively unimpaired individuals and its interaction with vascular medication use","volume":"3","author":"Kobe","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.3233\/JAD-220872_ref7","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1001\/jamaneurol.2022.1261","article-title":"Association of aortic stiffness and pressure pulsatility with global amyloid-beta and regional tau burden among framingham heart study participants without dementia","volume":"79","author":"Cooper","year":"2022","journal-title":"JAMA Neurol"},{"key":"10.3233\/JAD-220872_ref8","doi-asserted-by":"crossref","first-page":"8573","DOI":"10.1523\/JNEUROSCI.1230-20.2020","article-title":"Associations between vascular function and tau PET are associated with global cognition and amyloid","volume":"40","author":"Albrecht","year":"2020","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-220872_ref9","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1161\/STROKEAHA.110.591552","article-title":"Brain glucose metabolism in vascular white matter disease with dementia: Differentiation from Alzheimer disease","volume":"41","author":"Pascual","year":"2010","journal-title":"Stroke"},{"key":"10.3233\/JAD-220872_ref10","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s00259-008-1039-z","article-title":"FDG-PET changes in brain glucose metabolism from normal cognition to pathologically verified Alzheimer\u2019s disease","volume":"36","author":"Mosconi","year":"2009","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.3233\/JAD-220872_ref11","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S1474-4422(03)00305-3","article-title":"Vascular cognitive impairment","volume":"2","author":"O\u2019Brien","year":"2003","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-220872_ref12","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1001\/jamaneurol.2018.1123","article-title":"Interactive associations of vascular risk and beta-amyloid burden with cognitive decline in clinically normal elderly individuals: Findings from the Harvard Aging Brain Study","volume":"75","author":"Rabin","year":"2018","journal-title":"JAMA Neurol"},{"key":"10.3233\/JAD-220872_ref13","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/BF02988596","article-title":"Cerebral blood flow and metabolic abnormalities in Alzheimer\u2019s disease","volume":"15","author":"Matsuda","year":"2001","journal-title":"Ann Nucl Med"},{"key":"10.3233\/JAD-220872_ref14","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1177\/0271678X20982383","article-title":"Causes and consequences of baseline cerebral blood flow reductions in Alzheimer\u2019s disease","volume":"41","author":"Bracko","year":"2021","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.3233\/JAD-220872_ref15","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41582-018-0014-y","article-title":"Cerebral small vessel disease: From a focal to a global perspective","volume":"14","author":"Ter Telgte","year":"2018","journal-title":"Nat Rev Neurol"},{"key":"10.3233\/JAD-220872_ref16","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1093\/brain\/awt188","article-title":"Contribution of cerebrovascular disease in autopsy confirmed neurodegenerative disease cases in the National Alzheimer\u2019s Coordinating Centre","volume":"136","author":"Toledo","year":"2013","journal-title":"Brain"},{"key":"10.3233\/JAD-220872_ref17","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.trci.2016.09.002","article-title":"Multiple comorbid neuropathologies in the setting of Alzheimer\u2019s disease neuropathology and implications for drug development","volume":"3","author":"Rabinovici","year":"2017","journal-title":"Alzheimers Dement (N Y)"},{"key":"10.3233\/JAD-220872_ref18","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1001\/archneur.60.3.393","article-title":"White matter structural integrity in healthy aging adults and patients with Alzheimer disease: A magnetic resonance imaging study","volume":"60","author":"Bartzokis","year":"2003","journal-title":"Arch Neurol"},{"key":"10.3233\/JAD-220872_ref19","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/alz.12410","article-title":"White matter hyperintensity topography in Alzheimer\u2019s disease and links to cognition","volume":"18","author":"Garnier-Crussard","year":"2022","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-220872_ref20","doi-asserted-by":"crossref","first-page":"e2125166","DOI":"10.1001\/jamanetworkopen.2021.25166","article-title":"Association of regional white matter hyperintensities with longitudinal Alzheimer-like pattern of neurodegeneration in older adults","volume":"4","author":"Rizvi","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.3233\/JAD-220872_ref21","doi-asserted-by":"crossref","first-page":"e1743","DOI":"10.1212\/WNL.0000000000011638","article-title":"Clinical and biological correlates of white matter hyperintensities in patients with behavioral-variant frontotemporal dementia and Alzheimer disease","volume":"96","author":"Huynh","year":"2021","journal-title":"Neurology"},{"key":"10.3233\/JAD-220872_ref22","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1136\/jnnp.2003.030858","article-title":"Enlarged perivascular spaces are associated with cognitive function in healthy elderly men","volume":"75","author":"Maclullich","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.3233\/JAD-220872_ref23","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.3174\/ajnr.A2541","article-title":"Assessment of the Virchow-Robin Spaces in Alzheimer disease, mild cognitive impairment, and normal aging, using high-field MR imaging","volume":"32","author":"Chen","year":"2011","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.3233\/JAD-220872_ref24","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.jalz.2016.06.004","article-title":"METACOHORTS for the study of vascular disease and its contribution to cognitive decline and neurodegeneration: An initiative of the Joint Programme for Neurodegenerative Disease Research","volume":"12","author":"Consortium","year":"2016","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-220872_ref25","doi-asserted-by":"publisher","DOI":"10.1002\/alz.12700"},{"key":"10.3233\/JAD-220872_ref26","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer\u2019s disease: Recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-220872_ref27","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1365-2796.2004.01380.x","article-title":"Mild cognitive impairment\u2013beyond controversies, towards a consensus: Report of the International Working Group on Mild Cognitive Impairment","volume":"256","author":"Winblad","year":"2004","journal-title":"J Intern Med"},{"key":"10.3233\/JAD-220872_ref28","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/nrn3114","article-title":"Neurovascular pathways to neurodegeneration in Alzheimer\u2019s disease and other disorders","volume":"12","author":"Zlokovic","year":"2011","journal-title":"Nat Rev Neurosci"},{"key":"10.3233\/JAD-220872_ref29","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s12916-014-0206-2","article-title":"The overlap between vascular disease and Alzheimer\u2019s disease\u2013lessons from pathology","volume":"12","author":"Attems","year":"2014","journal-title":"BMC Med"},{"key":"10.3233\/JAD-220872_ref30","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1161\/STROKEAHA.117.019309","article-title":"Burden of dilated perivascular spaces, an emerging marker of cerebral small vessel disease, is highly heritable","volume":"49","author":"Duperron","year":"2018","journal-title":"Stroke"},{"key":"10.3233\/JAD-220872_ref31","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1136\/jnnp-2017-316603","article-title":"CSF beta-amyloid and white matter damage: A new perspective on Alzheimer\u2019s disease","volume":"89","author":"Pietroboni","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.3233\/JAD-220872_ref32","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1212\/WNL.0000000000002352","article-title":"Periventricular hyperintensities are associated with elevated cerebral amyloid","volume":"86","author":"Marnane","year":"2016","journal-title":"Neurology"},{"key":"10.3233\/JAD-220872_ref33","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/s41582-020-0312-z","article-title":"Perivascular spaces in the brain: Anatomy, physiology and pathology","volume":"16","author":"Wardlaw","year":"2020","journal-title":"Nat Rev Neurol"},{"key":"10.3233\/JAD-220872_ref34","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/NEN.0b013e31825018f7","article-title":"Correlation of Alzheimer disease neuropathologic changes with cognitive status: A review of the literature","volume":"71","author":"Nelson","year":"2012","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.3233\/JAD-220872_ref35","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1750-1326-4-48","article-title":"Alzheimer\u2019s disease: Synaptic dysfunction and Abeta","volume":"4","author":"Shankar","year":"2009","journal-title":"Mol Neurodegener"},{"key":"10.3233\/JAD-220872_ref36","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.biocel.2007.07.013","article-title":"Mechanisms of A beta mediated neurodegeneration in Alzheimer\u2019s disease","volume":"40","author":"Crouch","year":"2008","journal-title":"Int J Biochem Cell Biol"},{"key":"10.3233\/JAD-220872_ref37","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.1073\/pnas.0609303104","article-title":"Phosphorylation of tau antagonizes apoptosis by stabilizing beta-catenin, a mechanism involved in Alzheimer\u2019s neurodegeneration","volume":"104","author":"Li","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-220872_ref38","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1212\/WNL.0000000000007654","article-title":"CNS small vessel disease: A clinical review","volume":"92","author":"Cannistraro","year":"2019","journal-title":"Neurology"},{"key":"10.3233\/JAD-220872_ref39","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1002\/alz.12091","article-title":"Age-stratified longitudinal study of Alzheimer\u2019s and vascular dementia patients","volume":"16","author":"Jorgensen","year":"2020","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-220872_ref40","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","article-title":"Alzheimer\u2019s disease","volume":"397","author":"Scheltens","year":"2021","journal-title":"Lancet"},{"key":"10.3233\/JAD-220872_ref41","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/s41582-021-00520-w","article-title":"Developing the ATX(N) classification for use across the Alzheimer disease continuum","volume":"17","author":"Hampel","year":"2021","journal-title":"Nat Rev Neurol"},{"key":"10.3233\/JAD-220872_ref42","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.jalz.2014.10.008","article-title":"Vascular contributions to cognitive impairment and dementia including Alzheimer\u2019s disease","volume":"11","author":"Snyder","year":"2015","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-220872_ref43","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.neuron.2020.11.019","article-title":"Vascular ApoE4 impairs behavior by modulating gliovascular function","volume":"109","author":"Yamazaki","year":"2021","journal-title":"Neuron"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-220872","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:06:58Z","timestamp":1777370818000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-220872"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,17]]},"references-count":43,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.3233\/jad-220872","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,17]]}}}